D. Z. Jalalova and D. A. Uralov 2025. Vascular Endothelial Growth Factor in Tear Fluid as a Marker of Treatment Effectiveness in Patients with Diabetic Retinopathy and Hypertensive Disease. American Journal of Biomedicine and Pharmacy. 2, 4 (Apr. 2025), 99–101. DOI:https://doi.org/10.51699/ajbp.v2i4.898.